Logo Image

Authors

Morgan Bayer
Latest Article

Real-World Data Show Enfortumab Vedotin Significantly Improves OS in Urothelial Carcinoma

Enfortumab vedotin significantly improved outcomes for patients with unresectable or metastatic urothelial carcinoma, according to real-world data.

Lindsay Fischer
Latest Article

Fostering Interactions That Heal

The pain and suffering that Eduardo Bruera, MD, FAAHPM, witnessed in patients during his clinical oncology rotations motivated him to reshape palliative care treatment.

Monica Janke, MD
Latest Article

Virtual Surveillance Visits with Symptom, Serum CA-125 Review May Offer Alternative for Ovarian Cancer Recurrence Detection.

In patients with ovarian cancer and pretreatment elevated CA-125 who achieved remission after frontline therapy, most recurrences are detected by rising CA-125 levels or symptoms.

Beau B Toskich, MD
Latest Article

Radiation Segmentectomy or Ablative External​ Beam Radiation Therapy as Initial Treatment for​ Solitary Hepatocellular Carcinoma: ​ A Multicenter Experience​

To describe clinical outcomes of both Y-90 RS and EBRT as initial therapy for solitary HCC.

Baptist Health Cancer Center
Latest Article

Baptist Health Miami Cancer Institute Celebrates 1000th Patient Treated Using Gamma Knife

Baptist Health Miami Cancer Institute treated its 1000th patient using Gamma Knife radiosurgery, an incisionless radiation therapy that precisely targets a tumor, importantly minimizing damage to otherwise healthy brain tissue.

Dr. Stephen Strickland
Latest Article

The Power of Patient-Provider Dialogue to Help Shape First-Line Treatment for Ph+ CML in Chronic Phase

This is a featured episode with expert discussions on the care of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, or Ph+ CML-CP, intended to inform US healthcare professionals.

Sylvester Comprehensive Cancer Center
Latest Article

Alcohol-Linked Cancer’s Toll Extends Far Beyond the Liver With Deaths Rising Across Age Groups

Alcohol-attributable cancer deaths in the U.S. doubled from about 11,400 in 1990 to more than 23,100 in 2023.

Rahma Warsame, MD
Latest Article

Mayo Clinic Physicians Seek to Address Bias in Medical Education

The clinical learning environment for medical trainees is the foundation of medical training programs.

J. Michael Guenther, M.D., Surgical Oncologist, St. Elizabeth Physicians, Edgewood, Kentucky
Latest Article

DecisionDx®-Melanoma is designed to identify cutaneous melanoma patients who can safely forgo sentinel lymph node biopsy without experiencing early recurrence

Sponsored content by Castle Biosciences, Inc. Dr. Guenther has not been compensated in connection with this article; Dr. Guenther receives compensation for his participation on the Speaker’s bureau for Castle Biosciences.

Meredith Pelster, MD, MSCI
Meredith Pelster, MD, MSCI

Meredith Pelster, MD, MSCI, of Sarah Cannon Research Institute

Latest Article

Dr Pelster on the MAPKeeper 301 Trial Evaluating Atebimetinib in First-Line Metastatic Pancreatic Cancer

Meredith Pelster, MD, MSCI, discusses the biomarker-agnostic design of the phase 3 MAPKeeper 301 trial of atebimetinib in metastatic pancreatic cancer.

Mayo Clinic
Latest Article

Body Composition Changes on CT Scans May Help Identify Pancreatic Cancer Risk

Patients with pancreatic cancer experience measurable changes in body composition years before diagnosis that differ from those seen in similar individuals without cancer.

Kaveh Zakeri, MD, MAS
Latest Article

Treatment Paradigms Are Shifting for Locally Advanced HPV-Positive Head and Neck Cancers

A personalized treatment paradigm based on hypoxia imaging is promising and may yield a successful, personalized de-escalation strategy for patients with HPV-associated oropharynx cancer.

Afton Woodward
Latest Article

Refined ADC Development Helps Weigh Biomarker-Based Decisions and Treatment Sequencing in Gynecologic Cancers

With multiple ADCs now available for use in gynecologic cancers, treatment decision-making incorporates biomarker nuances and raises sequencing questions.

Jeff Patton, MD
Laura Van Metre Baum, MD
Latest Article

Normalizing Motherhood in Medicine

Hematology/oncology programs can make it easier and more rewarding for would-be mothers to participate in fellowship.

Colleen Moretti
Latest Article

Darolutamide Plus ADT/Docetaxel Elicits Survival Benefit Across Subgroups in mHSPC

The addition of darolutamide to androgen deprivation therapy and docetaxel prolonged overall survival in patients with metastatic hormone-sensitive prostate cancer, irrespective of disease volume or disease risk.

Michelle T. Chi, MD
Latest Article

Practical Considerations for Fellows Treating VTE

Most hematology/oncology fellows will care for patients with venous thromboembolism throughout their training and long after their graduation from fellowship. Here are some practical considerations when treating a patient with an acute VTE.

Mark Alwardt
Latest Article

Oral Oncolytics Will Require Health Care System to Adapt

Judging from the drug pipeline, the future of oncology is oral chemotherapy.

Devon Womack
Latest Article

Providing Timely Cancer Care Access Is Crucial Amid Growing Patient Volume

A closer look at some of the approaches being used across The US Oncology Network to improve patient access can provide helpful insight into how practices can meet the growing need for their services.

UW School of Medicine
Latest Article

Christian Capitini Named Director of the UW Carbone Cancer Center

Christian Capitini has been named the next director of the University of Wisconsin Carbone Cancer Center.

Khalid Matin, MD, FACP
Latest Article

Community-Based Programs Have the Power to Remove Clinical Trial Barriers

Homogeneous trials present a missed opportunity to discover treatments that might be highly successful in a particular subset of patients.

Sponsored Q&A by Dr. Wang
Dr. Robert Dreicer
Jane Delartigue, PhD
Latest Article

Tumor Agnostic Role of TMB Biomarker Faces Challenges

Although tumor mutational burden is established as a clinically informative feature of tumors, its optimal use in therapeutic decision-making faces many challenges, and we are only beginning to fully understand its strengths and limitations.

Abramson Cancer Center
Latest Article

Julia “Julie” Borrelli Named Chair of the Abramson Cancer Center Director's Leadership Council

Julia “Julie” Borrelli has been appointed chair of the Abramson Cancer Center Director's Leadership Council.

Paul V. Viscuse, MD
Latest Article

Applying ASCO GU 2024 Data to Clinical Practice in Bladder, RCC Care

Paul V. Viscuse, MD, spotlights key data from the 2024 Genitourinary Cancers Symposium in bladder cancer and renal cell carcinoma.

Jacob N. Stein, MD, MPH
Latest Article

From Anguish to Action: Turning Despair Into Efforts to Improve Racial Equity

Oncology fellows at the University of North Carolina turned their despair over the murders of George Floyd and Breonna Taylor into an effort to improve racial equity.

Timothy J. Brown, MD
Latest Article

Finding the Optimal Therapeutic Sequence for Advanced Hepatocellular Carcinoma

Several breakthroughs in recent years have rapidly shifted the treatment landscape for advanced HCC.

Tracy Ann Politowicz
Latest Article

FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL

The FDA has approved pirtobrutinib for the treatment of adult patients with previously untreated CLL or SLL harboring no known 17p deletion.

American Oncology Network
Latest Article

American Oncology Network Celebrates Momentous Five-Year Anniversary of Closing the Cancer Care Gap

American Oncology Network, one of the fastest-growing community oncology networks in the United States, proudly celebrated its fifth anniversary, commemorating a half-decade of excellence in advancing community oncology and driving value-based care initiatives to close the cancer care gap.